Cancer survivors are the primary recipients of a survivorship care plan, which is designed to outline their long-term treatment effects and improve their quality of life as evidenced by [1], [2], [3], and [4]. Furthermore, [5] highlights the clinical relevance of this relationship by measuring the prevalence of survivorship care plan delivery among this specific patient population.